| Today, Tue, Dec 1, 2009 | | • | These Growth Stocks Are Also Good Values
at Motley Fool (Tue 11:14am)
| | • | Mark Hulbert: A dirty dozen
at MarketWatch (Tue 12:01am)
| | Fri, Nov 27, 2009 | | • | [$$] Sorting Through the Stock Laggards of 2009
at Barrons.com (Fri, Nov 27)
| | Wed, Nov 25, 2009 | | • | Cephalon Settles Barr Challenge
Zacks.com (Wed, Nov 25)
| | Tue, Nov 24, 2009 | | • | [$$] Stocks in the Spotlight Monday
at Barrons.com (Tue, Nov 24)
| | • | H-P: Analysts' Upgrades, Downgrades
at TheStreet.com (Tue, Nov 24)
| | • | Cephalon upgraded by Jefferies & Co
Briefing.com (Tue, Nov 24)
| | • | [$$] Verizon Advances 3%; Chevron, Exxon Rise
at The Wall Street Journal Online (Tue, Nov 24)
| | Mon, Nov 23, 2009 | | • | CEPHALON INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E
EDGAR Online (Mon, Nov 23)
| | • | [$$] The Good News and the Bad News
at The Wall Street Journal Online (Mon, Nov 23)
| | • | Monday Options Recap
at Seeking Alpha (Mon, Nov 23)
| | • | Nov. 23: Unusual Volume Leaders
at CNBC (Mon, Nov 23)
| | • | UPDATE - Cephalon stock drops after mixed drug trial data
at Reuters (Mon, Nov 23)
| | • | Early-Market Movers: Origin Agritech Limited, Ciena Corp
at Fox Business (Mon, Nov 23)
| | • | Drug stocks advance; Cephalon falls on study
at MarketWatch (Mon, Nov 23)
| | • | A Big Upgrade for Allos Therapeutics
at Motley Fool (Mon, Nov 23)
| | • | Mixed results from Ception, Cephalon on Cinquil
at bizjournals.com (Mon, Nov 23)
| | • | Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
PR Newswire (Mon, Nov 23)
| | Sun, Nov 22, 2009 | | • | Valeant may fall if new drug disappoints-Barron's
at Reuters (Sun, Nov 22)
| | Fri, Nov 20, 2009 | | • | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
Wall Street Transcript (Fri, Nov 20)
|
Add CEPH News to My Yahoo!:
 
| |
|
1.22% Nasdaq 
Headlines
